MedPath

BABYDIET-Study - Primary Prevention of Type 1 Diabetes in Relatives at Increased Genetic Risk

Not Applicable
Conditions
Type 1 Diabetes
Interventions
Other: Glutenfree diet during the first year of life
Registration Number
NCT01115621
Lead Sponsor
Institut fur Diabetesforschung, Munich, Germany
Brief Summary

The major goals of this project are to determine whether primary intervention through delayed introduction of dietary gluten is feasible and could reduce the incidence of islet autoimmunity in high-risk first degree relatives of patients with type 1 diabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Newborn offspring or siblings of patients with type 1 diabetes with a HLA genotype conferring a high diabetes risk
Exclusion Criteria
  • If infants have an illness or birth defect that precludes long-term follow-up or involves use of treatment that may alter the natural history of diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Glutenfree dietGlutenfree diet during the first year of lifeGlutenfree diet during the first year of life
Primary Outcome Measures
NameTimeMethod
Effect of dietary intervention on the development of islet autoantibodies3 years

Primary outcome is to compare the prevalence of iselt autoantibodies between children participating in the dietary intervention and the control group.

Secondary Outcome Measures
NameTimeMethod
Effect of dietary intervention on the development of Type 1 diabetes.10 years

Secondary outcome is to compare the prevalence of type 1 diabetes between children participating in the dietary intervention and the control group

Trial Locations

Locations (1)

Institut für Diabetesforschung

🇩🇪

München, Germany

© Copyright 2025. All Rights Reserved by MedPath